Castleark Management’s Integra LifeSciences IART Stock Holding History

Castleark Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-91,135	Closed	-$5.31M	–	360
2019 Q4	$5.31M	Sell	91,135 -89,260	-49%	-$5.31M	0.21%	146
2019 Q3	$10.8M	Buy	+180,395	New	+$10.7M	0.44%	69
2018 Q3	–	Sell	-281,481	Closed	-$18.1M	–	390
2018 Q2	$18.1M	Buy	+281,481	New	+$17.4M	0.56%	43
2017 Q2	–	Sell	-161,053	Closed	-$6.79M	–	409
2017 Q1	$6.79M	Sell	161,053 -191,125	-54%	-$8.17M	0.21%	156
2016 Q4	$15.1M	Buy	352,178 +33,638	+11%	+$1.37M	0.48%	48
2016 Q3	$13.1M	Buy	318,540 +96,240	+43%	+$4.03M	0.4%	61
2016 Q2	$8.87M	Buy	+222,300	New	+$8M	0.28%	99

Other funds holding IART

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Castleark Management's IART Position: Q1 2020 in Review

Castleark Management sold out of Integra LifeSciences (IART) in Q1 2020, closing a stake of 91,135 shares — an estimated $5.31M sold.

Castleark Management first reported a position in IART in Q2 2016 and held it in 7 quarters. The position peaked at $18.1M in Q2 2018. 258 funds tracked by Wall St. Rank hold IART as of Q1 2020.

Castleark Management reported no remaining Integra LifeSciences position as of Q1 2020 after selling out during the quarter.
Castleark Management sold 91,135 Integra LifeSciences shares in Q1 2020, an estimated $5.31M.
Castleark Management first reported a position in Integra LifeSciences in Q2 2016 and held it in 7 quarters.
Castleark Management's Integra LifeSciences position peaked at $18.1M in Q2 2018.
258 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2020.

Based on Castleark Management's 13F filing for Q1 2020, filed 13 May 2020.